FDA approves Italfarmaco’s Duvyzat for duchenne muscular dystrophy treatment

In a significant advancement for the treatment of Duchenne muscular dystrophy (DMD), Italfarmaco S.p.A. has announced the U.S. Food and Drug Administration (FDA) approval of ... Read More